Proteomics in the analysis of prostate cancer.
Ludwig Institute for Cancer Research and Department of Biochemistry and Molecular Biology, Royal Free and University College London Medical School, London, UK.
Soren
S
Naaby-Hansen
Kohji
K
Nagano
Piers
P
Gaffney
John R W
JR
Masters
Rainer
R
Cramer
D000951:Antigens, Neoplasm / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D015180:Electrophoresis, Gel, Two-Dimensional / Q000379:methods; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008297:Male; D009363:Neoplasm Proteins / Q000032:analysis*; D011471:Prostatic Neoplasms / Q000737:chemistry*; D040901:Proteomics; D012333:RNA, Messenger / Q000032:analysis; D015398:Signal Transduction; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / Q000379:methods
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D012333:RNA, Messenger